Day: May 29, 2020

LAKE FOREST, Calif, May 28, 2020 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), an advanced product design, manufacturer and distributor with emphasis on innovative products, currently focused on tools and other accessories for the professional and do-it-yourself construction industries, today announced the pricing of an underwritten public offering of 18,000,000 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants to purchase up to 18,000,000 shares of the Company’s common stock. Each share of common stock or pre-funded warrant is being sold together with a warrant to purchase one share of common stock. The combined purchase price for one share of common stock and warrant to purchase one share of common stock will be $1.00....

MELBOURNE, Australia, May 28, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced public offering of 3,500,000 American Depositary Shares (“ADSs”), each representing six hundred (600) of the Company’s ordinary shares, at an effective purchase price of $2.00 per ADS, and 500,000 pre-funded warrants, at an effective purchase price of $1.9999 per pre-funded warrant, for aggregate gross proceeds of approximately $8.0 million. Each pre-funded warrant sold in this offering is exercisable into one ADS at an exercise price of $0.0001 per ADS.H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.The Company  intends to use the net proceeds from this offering...

TORONTO, May 28, 2020 (GLOBE NEWSWIRE) — Petrolympic Ltd. (TSX-V: PCQ) (the “Company”), wishes to announce that the Company is postponing the reporting of its first quarter Financial Statements and Management’s Discussion and Analysis (“MD&A”) as a result of delays caused by the COVID-19 pandemic. The Company aims to file these documents by the end of June 2020 under the terms of the 45-day extension announced by the Ontario Securities Commission under the “Ontario Instrument 51-502”, dated March 23, 2020.The Company ratifies that management and the Company’s insiders remain subject to the Company’s Insider Trading Policy and confirms that there have been no material business developments since May 2020 when the Company filed its annual audited financial results other than as announced.NEITHER THE TSX VENTURE EXCHANGE...

WILLIAMSVILLE, N.Y., May 28, 2020 (GLOBE NEWSWIRE) — National Fuel Gas Company (NYSE: NFG) (the “Company”) today announced that the Company has priced an underwritten public offering of 3,800,000 shares of the Company’s common stock (the “Common Stock”) at a price to the public of $39.50 per share. The Company is conducting the offering pursuant to an effective registration statement under the Securities Act of 1933. The underwriters have a 30-day option to purchase up to an additional 570,000 shares of Common Stock. The offering is scheduled to be completed on June 2, 2020, subject to customary closing conditions.The net proceeds to the Company, after deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $144.8 million (exclusive of the underwriters’ 30-day option...

SYDNEY, Australia, May 29, 2020 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce that it has received a €2,173,454 (~ US$2,407,817) research and development (R&D) tax incentive payment in cash from the French Government under its Crédit d’Impôt Recherche scheme (CIR).The “Crédit d’Impôt Recherche” (CIR), meaning “Research Tax Credit”, is a French government tax incentive by which French companies conducting research and development activities in Europe can be reimbursed 30% of their eligible expenditure.Immutep qualifies to receive CIR tax incentive through its subsidiary Immutep S.A.S. due to the research and development conducted in its laboratory at Châtenay-Malabry...